{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:45:37Z","timestamp":1793234737302,"version":"4.5.0"},"reference-count":70,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Bladder cancer (BC) is the 10th most common cancer in the world. The therapeutic spectrum of BC is broad and is constantly expanding. Despite the wide clinical use of photodynamic diagnosis (PTD) for BC, PDT has not been sufficiently investigated in the treatment landscape of BC. We performed an online search of the PubMed database using these keywords: photodynamic therapy, bladder cancer, urothelial carcinoma, in vivo, in vitro, cell line, animal model. Reviews, case reports, and articles devoted to photodynamic diagnostics and the photodynamic therapy of tumors other than urothelial carcinoma were excluded. Of a total of 695 publications, we selected 20 articles with clinical data, 34 articles on in vivo PDT, and 106 articles on in vitro data. The results presented in animal models highlight the potential use of PDT in the neoadjuvant or adjuvant setting to reduce local recurrence in the bladder and upper urinary tracts. Possible regimens include the combination of PDT with intravesical chemotherapy for improved local tumor control or the integration of vascular-targeted PDT in combination with modern systemic drugs in order to boost local response. We summarize available evidence on the preclinical and clinical application of PDT for urothelial carcinoma in order to explain the current trends and future perspectives.<\/jats:p>","DOI":"10.3390\/ijms25020960","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T07:47:16Z","timestamp":1705045636000},"page":"960","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Photodynamic Therapy: Current Trends and Potential Future Role in the Treatment of Bladder Cancer"],"prefix":"10.3390","volume":"25","author":[{"given":"Maxim","family":"Kochergin","sequence":"first","affiliation":[{"name":"Department of Urology and Neurourology, BG Unfallkrankenhaus Berlin, 12683 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Fahmy","sequence":"additional","affiliation":[{"name":"Department of Urology, Universiti Putra Malaysia (UPM), Serdang 43400, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7230-579X","authenticated-orcid":false,"given":"Anastasios","family":"Asimakopoulos","sequence":"additional","affiliation":[{"name":"Urology Unit, Fondazione PTV Policlinico Tor Vergata, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1934-0086","authenticated-orcid":false,"given":"Gerit","family":"Theil","sequence":"additional","affiliation":[{"name":"University Clinic and Polyclinic of Urology, University Hospital of Halle, Martin-Luther University Halle-Wittenberg, 06099 Halle, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Zietz","sequence":"additional","affiliation":[{"name":"University Clinic and Polyclinic of Urology, University Hospital of Halle, Martin-Luther University Halle-Wittenberg, 06099 Halle, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Bialek","sequence":"additional","affiliation":[{"name":"University Clinic and Polyclinic of Urology, University Hospital of Halle, Martin-Luther University Halle-Wittenberg, 06099 Halle, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Tiberi","sequence":"additional","affiliation":[{"name":"Department of Urology and Neurourology, BG Unfallkrankenhaus Berlin, 12683 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Gakis","sequence":"additional","affiliation":[{"name":"University Clinic and Polyclinic of Urology, University Hospital of Halle, Martin-Luther University Halle-Wittenberg, 06099 Halle, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,12]]},"reference":[{"key":"ref_1","unstructured":"(2022, August 20). Cancer Today [Internet]. Available online: http:\/\/gco.iarc.fr\/today\/home."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder Cancer: A Review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrc1071","article-title":"Photodynamic therapy for cancer","volume":"3","author":"Dolmans","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jnci\/90.12.889","article-title":"Photodynamic therapy","volume":"90","author":"Dougherty","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1751-1097.1992.tb04222.x","article-title":"How does photodynamic therapy work?","volume":"55","author":"Henderson","year":"1992","journal-title":"Photochem. Photobiol."},{"key":"ref_6","first-page":"2151","article-title":"Vascular accumulation of a novel photosensitizer, MV6401, causes selective thrombosis in tumor vessels after photodynamic therapy","volume":"62","author":"Dolmans","year":"2002","journal-title":"Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrc1894","article-title":"Photodynamic therapy and anti-tumour immunity","volume":"6","author":"Castano","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3322\/caac.20114","article-title":"Photodynamic therapy of cancer: An update","volume":"61","author":"Agostinis","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2217\/14796694.2.1.53","article-title":"The future of photodynamic therapy in oncology","volume":"2","author":"Allison","year":"2006","journal-title":"Future Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pdpdt.2017.02.017","article-title":"Tetrahydroporphyrin-tetratosylat (THPTS): A near-infrared photosensitizer for targeted and efficient photodynamic therapy (PDT) of human bladder carcinoma. An in vitro study","volume":"18","author":"Weimann","year":"2017","journal-title":"Photodiagn. Photo. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jphotobiol.2016.08.044","article-title":"Antitumor activity evaluation of meso-tetra (pyrrolidine substituted) pentylporphin-mediated photodynamic therapy in vitro and in vivo","volume":"163","author":"Zhang","year":"2016","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5946\/ce.2013.46.1.24","article-title":"Photodynamic therapy (PDT): PDT mechanisms","volume":"46","author":"Allison","year":"2013","journal-title":"Clin. Endosc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/cas.15193","article-title":"Current status of photodynamic technology for urothelial cancer","volume":"113","author":"Inoue","year":"2022","journal-title":"Cancer Sci."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Kubrak, T.P., Ko\u0142odziej, P., Sawicki, J., Mazur, A., Koziorowska, K., and Aebisher, D. (2022). Some Natural Photosensitizers and Their Medicinal Properties for Use in Photodynamic Therapy. Molecules, 27.","DOI":"10.3390\/molecules27041192"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"M\u00fchleisen, L., Alev, M., Unterweger, H., Subatzus, D., P\u00f6ttler, M., Friedrich, R.P., Alexiou, C., and Janko, C. (2017). Analysis of Hypericin\u2014Mediated Effects and Implications for Targeted Photodynamic Therapy. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18071388"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Madar-Balakirski, N., Tempel-Brami, C., Kalchenko, V., Brenner, O., Varon, D., Scherz, A., and Salomon, Y. (2010). Permanent occlusion of feeding arteries and draining veins in solid mouse tumors by vascular targeted photodynamic therapy (VTP) with Tookad. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010282"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"112468","DOI":"10.1016\/j.ejmech.2020.112468","article-title":"Platinum(II) ring-fused chlorins as efficient theranostic agents: Dyes for tumor-imaging and photodynamic therapy of cancer","volume":"200","author":"Laranjo","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Kubrak, T., Karaku\u0142a, M., Czop, M., Kawczyk-Krupka, A., and Aebisher, D. (2022). Advances in Management of Bladder Cancer-The Role of Photodynamic Therapy. Molecules, 27.","DOI":"10.3390\/molecules27030731"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"7623","DOI":"10.2147\/IJN.S179226","article-title":"Enhanced photo\/chemo combination efficiency against bladder tumor by encapsulation of DOX and ZnPC into in situ-formed thermosensitive polymer hydrogel","volume":"13","author":"Huang","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1021\/acs.bioconjchem.6b00519","article-title":"Mitochondria-Targeted Photodynamic Therapy with a Galactodendritic Chlorin to Enhance Cell Death in Resistant Bladder Cancer Cells","volume":"27","author":"Pereira","year":"2016","journal-title":"Bioconjugate Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"990","DOI":"10.7150\/thno.22465","article-title":"O2-generating MnO2 nanoparticles for enhanced photodynamic therapy of bladder cancer by ameliorating hypoxia","volume":"8","author":"Lin","year":"2018","journal-title":"Theranostics"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"102256","DOI":"10.1016\/j.pdpdt.2021.102256","article-title":"Mitochondrial heat shock protein mortalin as potential target for therapies based on oxidative stress","volume":"34","author":"Pagliarone","year":"2021","journal-title":"Photodiagn. Photo. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jphotobiol.2006.02.001","article-title":"Hypericum perforatum, L. extract\u2014Novel photosensitizer against human bladder cancer cells","volume":"84","author":"Stavropoulos","year":"2006","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1056\/NEJM198711123172003","article-title":"Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder","volume":"317","author":"Prout","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1039\/b705763f","article-title":"Hypericin-mediated photodynamic therapy in combination with Avastin (bevacizumab) improves tumor response by downregulating angiogenic proteins","volume":"6","author":"Bhuvaneswari","year":"2007","journal-title":"Photochem. Photobiol. Sci."},{"key":"ref_26","first-page":"496","article-title":"Morphological study of the combined effect of purpurin derivatives and light on transplantable rat bladder tumors","volume":"47","author":"Morgan","year":"1987","journal-title":"Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1751-1097.1989.tb04152.x","article-title":"Distribution and elimination of Photofrin II in mice","volume":"50","author":"Bellnier","year":"1989","journal-title":"Photochem. Photobiol."},{"key":"ref_28","first-page":"643","article-title":"Photodynamic therapy in the treatment of subcutaneously implanted human bladder tumour","volume":"62","author":"Han","year":"1992","journal-title":"ANZ J. Surg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1751-1097.1996.tb03033.x","article-title":"A comparison of functional bladder damage after intravesical photodynamic therapy with three different photosensitizers","volume":"63","author":"Post","year":"1996","journal-title":"Photochem. Photobiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000139403","article-title":"Accumulation of porphyrins in plasma and tissues of dogs after delta-aminolevulinic acid administration: Implications for photodynamic therapy","volume":"52","author":"Egger","year":"1996","journal-title":"Pharmacology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1751-1097.1998.tb09457.x","article-title":"Biodistribution of Photofrin II and 5-aminolevulinic acid-induced protoporphyrin IX in normal rat bladder and bladder tumor models: Implications for photodynamic therapy","volume":"67","author":"Xiao","year":"1998","journal-title":"Photochem. Photobiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/10731199909117485","article-title":"Induction of superficial bladder tumors in the female Fischer 344 rats with AY-27 tumor cells for the study of diffusion and localization of hemoglobin derived components (hematoporphyrin derivative) in view of photochemotherapy","volume":"27","author":"Bisson","year":"1999","journal-title":"Artif. Cells Blood Substit. Biotechnol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ijc.10595","article-title":"A new method of implanting orthotopic rat bladder tumor for experimental therapies","volume":"102","author":"Bisson","year":"2002","journal-title":"Int. J. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1097\/01.ju.0000135816.46544.74","article-title":"Kinetics, biodistribution and therapeutic efficacy of hexylester 5-aminolevulinate induced photodynamic therapy in an orthotopic rat bladder tumor model","volume":"172","author":"Didelon","year":"2004","journal-title":"J. Urol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.juro.2008.10.144","article-title":"Preventing bladder tumor implantation with photodynamic therapy in a rat model mimicking post-fluorescence guided transurethral resection","volume":"181","author":"Berrahmoune","year":"2009","journal-title":"J. Urol."},{"key":"ref_36","first-page":"1099","article-title":"In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors","volume":"18","author":"Kamuhabwa","year":"2001","journal-title":"Int. J. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ijc.1594","article-title":"Biodistribution of hypericin in orthotopic transitional cell carcinoma bladder tumors: Implication for whole bladder wall photodynamic therapy","volume":"97","author":"Kamuhabwa","year":"2002","journal-title":"Int. J. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1097\/01.ju.0000176475.40669.07","article-title":"Photodynamic therapy with PAD-S31, a new hydrophilic chlorin photosensitizer, in an orthotopic rat bladder tumor model","volume":"174","author":"Asanuma","year":"2005","journal-title":"J. Urol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/lsm.22010","article-title":"A novel homogeneous irradiation fiber probe for whole bladder wall photodynamic therapy","volume":"44","author":"Miyazaki","year":"2012","journal-title":"Lasers Surg. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1562\/0031-8655(2001)073<0403:IBPTAB>2.0.CO;2","article-title":"Interaction between photodynamic therapy and BCG immunotherapy responsible for the reduced recurrence of treated mouse tumors","volume":"73","author":"Korbelik","year":"2001","journal-title":"Photochem. Photobiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/cas.12147","article-title":"Photodynamic therapy involves an antiangiogenic mechanism and is enhanced by ferrochelatase inhibitor in urothelial carcinoma","volume":"104","author":"Inoue","year":"2013","journal-title":"Cancer Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1039\/c7pp00176b","article-title":"Photochemical internalization in bladder cancer\u2014Development of an orthotopic in vivo model","volume":"16","author":"Gederaas","year":"2017","journal-title":"Photochem. Photobiol. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/iju.13878","article-title":"Effectiveness of the combination of vascular targeted photodynamic therapy and anti-cytotoxic T-lymphocyte-associated antigen 4 in a preclinical mouse model of urothelial carcinoma","volume":"26","author":"Corradi","year":"2019","journal-title":"Int. J. Urol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1038\/s41598-021-84184-y","article-title":"Neoadjuvant vascular-targeted photodynamic therapy improves survival and reduces recurrence and progression in a mouse model of urothelial cancer","volume":"11","author":"Rosenzweig","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"15550","DOI":"10.1039\/C5CC06561E","article-title":"Dual functionality of phosphonic-acid-appended phthalocyanines: Inhibitors of urokinase plasminogen activator and anticancer photodynamic agents","volume":"51","author":"Venkatramaiah","year":"2015","journal-title":"Chem. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0022-5347(01)66191-3","article-title":"Photodynamic therapy on rat urinary bladder with intravesical instillation of 5-aminolevulinic acid: Light diffusion and histological changes","volume":"155","author":"Chang","year":"1996","journal-title":"J. Urol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Alvim, R.G., Georgala, P., Nogueira, L., Somma, A.J., Nagar, K., Thomas, J., Alvim, L., Riegel, A., Hughes, C., and Chen, J. (2021). Combined OX40 Agonist and PD-1 Inhibitor Immunotherapy Improves the Efficacy of Vascular Targeted Photodynamic Therapy in a Urothelial Tumor Model. Molecules, 26.","DOI":"10.3390\/molecules26123744"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1011-1344(96)07378-2","article-title":"Electromotive diffusion (EMD) and photodynamic therapy with delta-aminolaevulinic acid (delta-ALA) for superficial bladder cancer","volume":"36","author":"Stenzl","year":"1996","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0022-5347(01)66854-X","article-title":"Integral photodynamic treatment of refractory superficial bladder cancer","volume":"154","author":"Kriegmair","year":"1995","journal-title":"J. Urol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-5347(01)63021-0","article-title":"Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder","volume":"160","author":"Nseyo","year":"1998","journal-title":"J. Urol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.pdpdt.2016.09.009","article-title":"5-Aminolevulinic acid in intraoperative photodynamic therapy of bladder cancer (results of multicenter trial)","volume":"16","author":"Filonenko","year":"2016","journal-title":"Photodiagn. Photo. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/bjc.1995.122","article-title":"Whole bladder wall photodynamic therapy for refractory carcinoma in situ of the bladder","volume":"71","author":"Uchibayashi","year":"1995","journal-title":"Br. J. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.urolonc.2012.02.007","article-title":"Photodynamic therapy of bladder cancer\u2014A phase I study using hexaminolevulinate (HAL)","volume":"31","author":"Bader","year":"2013","journal-title":"Urol. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/clm.1996.14.271","article-title":"Photodynamic therapy in the management of bladder cancer","volume":"14","author":"Nseyo","year":"1996","journal-title":"J. Clin. Laser Med. Surg."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0022-5347(01)63932-6","article-title":"Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of upper tract urothelial tumors","volume":"159","author":"Waidelich","year":"1998","journal-title":"J. Urol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1464-410X.2005.05506.x","article-title":"A phase-1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinoma","volume":"95","author":"Skyrme","year":"2005","journal-title":"BJU Int."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1464-410X.2002.02743.x","article-title":"Photodynamic therapy for superficial bladder cancer under local anaesthetic","volume":"89","author":"Shackley","year":"2002","journal-title":"BJU Int."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/S0022-5347(05)66239-8","article-title":"Clinical experience with 5-aminolevulinic acid and photodynamic therapy for refractory superficial bladder cancer","volume":"165","author":"Waidelich","year":"2001","journal-title":"J. Urol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1349-7006.1993.tb02823.x","article-title":"Photodynamic therapy for cancers: A clinical trial of porfimer sodium in Japan","volume":"84","author":"Kato","year":"1993","journal-title":"Jpn. J. Cancer Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0090-4295(97)00211-2","article-title":"Phase I trial of photodynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladder","volume":"50","author":"Walther","year":"1997","journal-title":"Urology"},{"key":"ref_61","first-page":"198","article-title":"Long-term experience with integral photodynamic therapy of TIS bladder carcinoma","volume":"146","author":"Jocham","year":"1989","journal-title":"Ciba Found. Symp."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.euf.2018.08.005","article-title":"Photodynamic Therapy in the Treatment of Bladder Cancer: Past Challenges and Current Innovations","volume":"4","author":"Railkar","year":"2018","journal-title":"Eur. Urol. Focus"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/s-0028-1098741","article-title":"BCG versus photodynamic therapy (PDT) for nonmuscle invasive bladder cancer-a multicentre clinical phase III study","volume":"40","author":"Jocham","year":"2009","journal-title":"Aktuelle Urol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0022-5347(17)41302-4","article-title":"Complications of whole bladder dihematoporphyrin ether photodynamic therapy","volume":"141","author":"Harty","year":"1989","journal-title":"J. Urol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0090-4295(99)80080-6","article-title":"Long-term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladder","volume":"45","author":"Baert","year":"1995","journal-title":"Urology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/php.13726","article-title":"Photodynamic Therapy for Bladder Cancers, A Focused Review\u2020","volume":"99","author":"Rahman","year":"2023","journal-title":"Photochem. Photobiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s12274-022-4646-2","article-title":"Platelet membrane-coated C-TiO2 hollow nanospheres for combined sonodynamic and alkyl-radical cancer therapy","volume":"16","author":"Guo","year":"2023","journal-title":"Nano Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"101170","DOI":"10.1016\/j.nantod.2021.101170","article-title":"Liquid exfoliation of TiN nanodots as novel sonosensitizers for photothermal-enhanced sonodynamic therapy against cancer","volume":"39","author":"Wang","year":"2021","journal-title":"Nano Today"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"101215","DOI":"10.1016\/j.apmt.2021.101215","article-title":"Titanium-based sonosensitizers for sonodynamic cancer therapy","volume":"25","author":"Yang","year":"2021","journal-title":"Appl. Mater. Today"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"100946","DOI":"10.1016\/j.nantod.2020.100946","article-title":"Recent progress of chemodynamic therapy-induced combination cancer therapy","volume":"35","author":"Wang","year":"2020","journal-title":"Nano Today"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/2\/960\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:45:27Z","timestamp":1760103927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/2\/960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,12]]},"references-count":70,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["ijms25020960"],"URL":"https:\/\/doi.org\/10.3390\/ijms25020960","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,12]]}}}